Tim is a Senior Consultant in the New York office, having joined Deallus in 2014. He is a seasoned project manager who has overseen numerous long- and short-term global engagements supporting clients in competitive landscapes, product launches, life cycle management, and early commercialization. His therapeutic area expertise includes oncology, cardiometabolics, and rare disease.
Prior to joining Deallus, Tim worked for a chemical startup where he interfaced with academic tech transfer managers and venture capital groups to commercialize small molecule collections for pharma screening centers. Leveraging the communications skills honed while working with diverse audiences, he spent 2 years working as a scientific editor for an international medical editing firm.
Tim holds a PhD in Organic Chemistry from the University of Illinois, where his research tackled drug discovery problems from the angles of high-throughput screening, computational informatics, RNA-protein binding interactions, and novel sensor technologies. His background allows him to draw on a deep technical expertise in mechanism of action and biomolecular interactions.